Literature DB >> 21924571

Audit of antibiotic therapy used in 66 cases of endocarditis.

E Demonchy1, P Dellamonica, P M Roger, E Bernard, E Cua, C Pulcini.   

Abstract

OBJECTIVES: We wanted to assess the quality of antibiotic therapy prescribed for infective endocarditis in our ward.
DESIGN: We conducted a retrospective audit of all adult patients with endocarditis hospitalized over a 3-year period in the Infectious Diseases Unit of the Nice University Hospital, France. The quality of antibiotic therapy was assessed using the 2004 European Society of Cardiology guidelines as a reference. Antibiotic therapy was considered as appropriate only if the five following items complied with guidelines: antibiotic, dose, route, interval of administration, and duration of antibiotic treatment.
RESULTS: Sixty-six patients were included, 63years of age on average. Antibiotic therapy complied with guidelines in 14% of the cases. The most frequent causes of inappropriate therapy were: gentamicin prescribed as a single daily dose in 55% (27/49) of the cases, unnecessary prescriptions of rifampin in 72% (18/25) of the cases, and too long duration of gentamicin course for staphylococcal endocarditis in 32% (9/28) of the cases. Antibiotic therapy was switched from intravenous to oral route in 29% of the patients (n=19), 18±9 days after starting therapy on average. These endocarditis were mainly left-sided (n=12) and/or complicated (n=15). There was no significant association between mortality and inappropriate antibiotic therapy (14% if inappropriate vs. 22%, P=0.62) or between mortality and oral switch (0% if oral switch vs. 21%, P=0.052).
CONCLUSIONS: Infective endocarditis antibiotic treatment rarely complied with the 2004 European guidelines, but this did not have a negative impact on mortality. Switching antibiotic therapy from intravenous to oral route was common, even for complicated left-sided endocarditis, and was associated with a favorable outcome in all cases.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21924571     DOI: 10.1016/j.medmal.2011.08.003

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  6 in total

Review 1.  The causative agents in infective endocarditis: a systematic review comprising 33,214 cases.

Authors:  Christiana T Vogkou; Nikolaos I Vlachogiannis; Leonidas Palaiodimos; Antonis A Kousoulis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-11       Impact factor: 3.267

2.  Factors associated with unfavorable outcome in a multicenter audit of 100 infective endocarditis.

Authors:  David Chirio; Marion Le Marechal; Pamela Moceri; Arnaud de la Chapelle; Sylvie Chaillou-Optiz; Anaïs Mothes; Cédric Foucault; Laurence Maulin; Chirine Parsaï; Pierre-Marie Roger; Elisa Demonchy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-10-15       Impact factor: 3.267

3.  Evaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective Endocarditis: A Narrative Review.

Authors:  Brad Spellberg; Henry F Chambers; Daniel M Musher; Thomas L Walsh; Arnold S Bayer
Journal:  JAMA Intern Med       Date:  2020-05-01       Impact factor: 21.873

4.  Oral switch versus standard intravenous antibiotic therapy in left-sided endocarditis due to susceptible staphylococci, streptococci or enterococci (RODEO): a protocol for two open-label randomised controlled trials.

Authors:  Adrien Lemaignen; Louis Bernard; Pierre Tattevin; Jean-Pierre Bru; Xavier Duval; Bruno Hoen; Solène Brunet-Houdard; Jean-Luc Mainardi; Agnes Caille
Journal:  BMJ Open       Date:  2020-07-14       Impact factor: 2.692

5.  Endocarditis in the Mediterranean Basin.

Authors:  F Gouriet; H Chaudet; P Gautret; L Pellegrin; V P de Santi; H Savini; G Texier; D Raoult; P-E Fournier
Journal:  New Microbes New Infect       Date:  2018-05-30

Review 6.  Current Evidence on Oral Antibiotics for Infective Endocarditis: A Narrative Review.

Authors:  Takaaki Kobayashi; Tomo Ando; Judy Streit; Poorani Sekar
Journal:  Cardiol Ther       Date:  2019-09-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.